Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity.
Flachenecker P, Henze T, Zettl UK
Eur Neurol. 2014 Feb 12; 71(5-6):271-279. Epub 2014 Feb 12. PMID: 24525548.Abstract